CytoDyn Inc (OTCMKTS: CYDY) shares gained more than 8% closing the day at $0.73. CYDY has a market cap of over 524.8M$. CYDY is a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications. The company had announced the appointment of Dr. Cyrus Arman as President effective July 9, 2022. Dr. Arman will be responsible for determining and leading the Company’s operating strategy for the future. It is anticipated that he will advance to Chief Executive Officer and be appointed to the Board of Directors within six months. Antonio Migliarese, who had been serving as interim President since late January, in addition to CFO, will resume his previous role as CFO.
Northwest Biotherapeutics, Inc (OTCMKTS: NWBO) closed the day at $0.65 up 1.48%. The stock opened at $0.64 and traded to a high of $0.65. The company currently has a market cap of 636M with a 52 week high of $2.05. In early July, the company had announced that an application for license of the manufacturing facility in Sawston, UK for commercial manufacturing of cellular therapies has been submitted to the Medicines and Healthcare Products Regulatory Agency (MHRA). The application builds upon the 3 licenses received for the Sawston facility in 2021.
American Battery Technology Co (OTCMKTS: ABML) closed the day in red, down 3.45%. The company had a 52 week low of $0.56 and a 52 week high of $1.95. On July 6th, the company confirmed to participate in industry and investor conferences this summer. The company’s CEO Ryan Melsert has been invited to share his industry insights on expert panels at these industry and investor conferences as noted below. “At this time when there is such unprecedented support for the lithium-ion battery metals industry from the federal government, state governments, strategic industry partners, and the investment community, it is important to continue to engage with each of our critical stakeholders and to support the industry on these expert panels,” stated ABTC CEO Ryan Melsert.
Humbl Inc (OTCMKTS: HMBL) had a red day with shares sliding more than 8.75%. The shares seem to be hovering close to its 52 week low of $0.045. In June the company announced that it has signed a brand endorsement relationship with Myles Garrett to promote its Web 3 blockchain platform.
For consideration of being featured on WallstreetPR, contact: Editor@Wallstreetpr.com